Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Nov 27;8(2):e1532764. doi: 10.1080/2162402X.2018.1532764

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This work was authored as part of the Contributor’s official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law.

This is an Open Access article that has been identified as being free of known restrictions under copyright law, including all related and neighboring rights (https://creativecommons.org/publicdomain/mark/1.0/). You can copy, modify, distribute and perform the work, even for commercial purposes, all without asking permission.

PMC Copyright notice

Figure 4. — Effects of N-809 treatment on NK cell gene expression. Healthy donor NK cells were incubated ±N-809 (37.5 ng/ml) for 24h prior to RNA isolation for RNASeq analysis using the NantOmics panel of immune related genes. (a) Heat map of gene expression analysis for genes that were up- or downregulated ≥3-fold in both donors after N-809 treatment compared to no treatment. (b) Graph depicting the fold change for the genes in (a). (c) Table showing the number of genes differentially expressed in N-809 treated cells vs. the untreated control.